Global Market Study on Scar Treatment: Asia to Witness Highest Growth by 2022


  • Published On : Jun-2015 |
  • Pages : 130 Pages |
  • Format :

Scar is a mark on the skin which is formed due to infection, injury, surgery, inflammation of tissue, burns, and acne. Scars can impact an individual’s mental and physical well-being, resulting in poor self esteem, altered social interactions, depression, and embarrassment. Scars can be of various sizes, shapes, and colors, depending on the age of scar, site of scar, and family history. Formation of scars is unpredictable and varies from person to person. Certain areas of the body such as the chest, back, ear lobes, and the shoulder are more at risk of scarring as compared to rest of the body. Scars on knees and shoulders can appear stretched or widened due to the healing process which occurs over movable joints.

North America is the largest market for scar treatment due to high disposable income in the country, which results in higher spending on personal care. The scar treatment market in Asia is expected to show high growth rates over the following five years. China and India are expected to be the fastest growing scar treatment markets in Asia. Some of the key driving forces for the scar treatment market in emerging markets are rise in disposable income, rising population, increasing prevalence of skin-related problems, growing focus on personal well being, and improving healthcare facilities in the region. 

Prevalence of skin problems such as photoaging is increasing due to excessive exposure to pollution and UV radiation, resulting in sunburns, and reduced skin elasticity. These conditions, without proper and timely treatment, can lead to formation of scars. Moreover, awareness about treating scars is increasing globally, which, in turn, is leading to rising spending on such treatments. Increasing appearance consciousness among consumers and technological advancements in scar treatment are some of the other factors driving growth of the market. However, high costs and risk of side effects of scar treatment are the factors inhibiting growth of the market.

This report provides in-depth analysis and estimation of the scar treatment market for the period 2015–2022, considering 2014 as the base year for calculation. Moreover, data pertaining to current market dynamics, including market drivers, restraints, trends, and recent developments, has been provided in the report. The scar treatment market is categorized on the basis of type of product, treatment, type of scar, and geography. Based on type of product, the market comprises creams, oils, gels, gel sheets, elastic wraps, and sprays. On the basis of treatment, the market is categorized as laser treatment, invasive surgical treatment, chemical peeling, cryosurgery, tissue fillers, and steroid injections. Based on type of scar, the market is categorized into keloid scars, acne scars, post-surgical scars, contracture scars, stretch marks, and hypertrophic scars. On the basis of geography, the report identifies and analyzes the market size and predictions for North America, Europe, Asia, and Rest of the World (RoW).

Some of the major players in the scar treatment market are Merz Pharma GmbH & Co. KGaA, Pacific World Corporation, Oculus Innovative Sciences, Inc., Valeant Pharmaceuticals International Inc., Avita Medical Limited, Enaltus, LLC, Revitol Corporation Inc., Scarguard Labs LLC, Quantum, Inc., and CCA industries Inc. These key market players have been profiled on the basis of attributes such as company overview, sustainability, financial overview, and recent developments.

In this report, the scar treatment is segmented as follows:

By product type

  • Creams
  • Oils
  • Gels
  • Gel sheets
  • Elastic wraps
  • Sprays

By treatment

  • Laser treatment
  • Invasive surgical treatment
  • Cryosurgery
  • Chemical peeling
  • Dermabrasion
  • Steroid injections
  • Tissue fillers

By scar type

  • Keloid scars
  • Contracture scars
  • Hypertrophic scars
  • Acne scars
  • Stretch marks
  • Post-surgical scars

By geography

  • North America
  • Europe
    • France, Germany, Italy, Spain, and the UK 
    • Eastern Europe
    • CIS
  • Asia
    • China
    • India
    • Japan
    • Others
  • Latin America
    • Argentina
    • Brazil
    • Others

Key features of this report

  • Drivers, restraints, and challenges shaping the scar treatment market dynamics
  • Latest innovations and key events in the industry
  • Analysis of business strategies of the top players
  • Scar treatment market estimates and forecast

The global scar treatment market is witnessing significant growth due to rising prevalence of skin disease and growing expenditure on personal care. Moreover, technological advancements in scar treatment and increasing appearance consciousness among consumers are also driving growth of the market. However, high costs of advanced scar treatments and side effects of various treatments inhibits growth of the market.

The scar treatment market is anticipated to grow from an estimated US$ 16,048.7 Mn in 2015 to US$ 31,904.8 Mn by 2022 at a CAGR of 10.3% during the forecast period. North America is the largest market for scar treatment, with post-surgical scars being the most common type of scars for which people opt for treatment. Asia is the fastest growing market; while laser treatment makes for the fastest growing type of treatment in the global scar treatment market.

Various types of scar treatment products include creams, oils, gels, gel sheets, elastic wraps, and sprays. The global scar treatment products market is expected to grow from an estimated US$ 9,472.0 Mn in 2015 to US$ 19,562.5 Mn in 2022 at a CAGR of 10.9% during the forecast period.

Top companies profiled in this report are:

  • Merz Pharma GmbH & Co. KGaA
  • Pacific World Corporation
  • Oculus Innovative Sciences, Inc.
  • Valeant Pharmaceuticals International Inc.
  • Avita Medical Limited
  • Enaltus, LLC.
  • Revitol Corporation Inc.
  • Scarguard Labs LLC
  • Quantum, Inc.
  • CCA industries Inc

Table of Content

Chapter 1 Preface 14
1.1 Report Description 14
1.2 Research Methodology 15
1.3 Assumptions 15

Chapter 2 Market Synopsis 16

Chapter 3 Porter’s Five Forces Analysis 18
3.1 Bargaining Power of Suppliers 18
3.2 Bargaining Power of Buyers 19
3.3 Threat of New Entrants 19
3.4 Threat of Substitutes 20
3.5 Intensity of Rivalry 20

Chapter 4 Market Overview 21
4.1 Market Definition 21
4.2 Market Drivers 22
      4.2.1 Rising prevalence of skin problems leading to scar formation 23
      4.2.2 Growing expenditure on personal care 23
      4.2.3 Increasing appearance consciousness among consumers 24
      4.2.4 Technological advancements in scar treatment 24
4.3 Impact Analysis of Market Drivers 25
4.4 Restraints 26
      4.4.1 High costs of scar treatment 26
      4.4.2 Risk of side effects 26
4.5 Impact Analysis of Market Restraints 27
4.6 Opportunities 28
      4.6.1 Rising demand for organic scar treatment products 28
4.7 Trends 28
      4.7.1 Growing online retailing of scar treatment products 28
      4.7.2 Increasing usage of silicon-based products for treating scars 29

Chapter 5 Global Market Size and Forecast 30

Chapter 6 Market Size and Forecast by Type of Scar 37
6.1 Post-surgical scars 37
6.2 Acne scars 39
6.3 Contracture scars 41
6.4 Stretch marks 44
6.5 Keloid scars 46
6.6 Hypertrophic scars 48

Chapter 7 Market Size and Forecast by Product Type 51
7.1 Creams 51
7.2 Oils 53
7.3 Gels 55
7.4 Gel sheets 57
7.5 Elastic wraps 59
7.6 Sprays 61

Chapter 8 Market Size and Forecast by Type of Scar Treatment 64
8.1 Dermabrasion 65
8.2 Laser Treatment 67
      8.2.1 Ablative laser resurfacing 68
      8.2.2 Non-ablative laser resurfacing 68
      8.2.3 Fractionated laser resurfacing 68
8.3 Chemical Peeling 70
8.4 Invasive surgical treatments 73
      8.4.1 Scar excision 73
      8.4.2 Z-plasty and W-plasty 74
      8.4.3 Skin grafting, skin flaps, and artificial skin 74
8.5 Cryosurgery 76
8.6 Tissue fillers 79
8.7 Steroid Injections 82

Chapter 9 Product Distribution Channel 85
9.1 Prescription Scar Treatment Products 86
      9.1.1 Supply chain analysis 87
9.2 Over-the-counter scar treatment product 88
      9.2.1 Supply chain analysis 91

Chapter 10 Market Size and Forecast by Geography 92
10.1 North America 92
      10.1.1 Scenario in the U.S. 92
      10.1.2 Scenario in Canada 93
10.2 Europe 95
      10.2.1 Scenario in the U.K. 95
      10.2.2 Scenario in Germany 95
      10.2.3 Scenario in France 96
      10.2.4 Scenario in Italy 96
      10.2.5 Scenario in Spain 97
10.3 Asia 99
      10.3.1 Scenario in Japan 99
      10.3.2 Scenario in China 100
      10.3.3 Scenario in India 100
10.4 Latin America 102
      10.4.1 Scenario in Brazil 103
10.5 Rest of the World 104

Chapter 11 Competitive Scenario 106
11.1 Competitive Benchmarking 106

Chapter 12 Company Profiles 108
12.1 Merz Pharma GmbH & Co. KGaA 108
      12.1.1 Company overview 108
      12.1.2 Products and services 108
      12.1.3 Financial performance 109
      12.1.4 Key development 109
12.2 Pacific World Corporation 111
      12.2.1 Company overview 111
      12.2.2 1.2.2. Products and services 111
      12.2.3 Financial performance 111
      12.2.4 Key developments 112
12.3 Oculus Innovative Sciences, Inc. 113
      12.3.1 Company overview 113
      12.3.2 1.3.2. Products and services 113
      12.3.3 Financial performance 114
      12.3.4 Key developments 114
12.4 Valeant Pharmaceuticals International Inc. 116
      12.4.1 Company overview 116
      12.4.2 1.4.2. Products and services 116
      12.4.3 Financial performance 117
      12.4.4 Key developments 117
12.5 Avita Medical Limited 118
      12.5.1 Company Overview 118
      12.5.2 Products and services 118
      12.5.3 Financial performance 119
      12.5.4 Key Developments 119
12.6 Enaltus, LLC. 121
      12.6.1 Company overview 121
      12.6.2 Products and services 121
      12.6.3 Financial performance 121
      12.6.4 Key developments 121
12.7 Revitol Corporation Inc. 122
      12.7.1 Company overview 122
      12.7.2 Products and services 122
      12.7.3 Financial performance 122
      12.7.4 Key developments 122
12.8 Scarguard Labs LLC 123
      12.8.1 Company overview 123
      12.8.2 Products and services 123
      12.8.3 Financial performance 123
      12.8.4 Key developments 123
12.9 Quantum, Inc. 124
      12.9.1 Company overview 124
      12.9.2 Products and services 124
      12.9.3 Financial performance 124
      12.9.4 Key developments 124
12.10 CCA Industries Inc. 125
      12.10.1 Company overview 125
      12.10.2 Products and services 125
      12.10.3 Financial performance 125
      12.10.4 Key development 126


List of Tables

TABLE 1 Market snapshot: Scar treatment market, 2014 and 2020 18
TABLE 2 Drivers for biopharmaceutical market: Impact analysis 30
TABLE 3 Restraints for biopharmaceutical market: Impact analysis 33
TABLE 4 Global scar treatment market size, by region, 2010 – 2013 (US$ Mn) 37
TABLE 5 Global scar treatment market size, by region, 2014 – 2020 (US$ Mn) 38
TABLE 6 Global scar treatment market size, by type, 2010 – 2013 (US$ Mn) 39
TABLE 7 Global scar treatment market size, by usage, 2014 – 2020 (US$ Mn) 40
TABLE 8 Global scar treatment market size, by therapeutic application, 2010 – 2013 (US$ Mn)  41
TABLE 9 Global scar treatment market size, by therapeutic application, 2014 – 2020 (US$ Mn)  42
TABLE 10 Global monoclonal antibodies market size, by region, 2010 – 2013 (US$ Mn) 44
TABLE 11 Global monoclonal antibody market size, by region, 2014 – 2020 (US$ Mn) 45
TABLE 12 Global recombinant proteins market size, by region, 2010 – 2013 (US$ Mn) 46
TABLE 13 Global recombinant proteins market size, by region, 2014 – 2020 (US$ Mn) 47
TABLE 14 Global granulocyte-colony stimulating factor market size, by region, 2010 – 2013 (US$ Mn) 48
TABLE 15 Global granulocyte-colony stimulating factor market size, by region, 2014 – 2020 (US$ Mn) 49
TABLE 16 Global interferons market size, by region, 2010 – 2013 (US$ Mn) 50
TABLE 17 Global interferons market size, by region, 2014 – 2020 (US$ Mn) 51
TABLE 18 Global recombinant human insulin market size, by region, 2010 – 2013 (US$ Mn) 52
TABLE 19 Global recombinant human insulin market size, by region, 2014 – 2020 (US$ Mn) 53
TABLE 20 Global erythropoietin market size, by region, 2010 – 2013 (US$ Mn) 54
TABLE 21 Global erythropoietin market size, by region, 2014 – 2020 (US$ Mn) 55
TABLE 22 Global vaccines market size, by region, 2010 – 2013 (US$ Mn) 56
TABLE 23 Global vaccines market size, by region, 2014 – 2020 (US$ Mn) 57
TABLE 24 Global growth hormones market size, by region, 2010 – 2013 (US$ Mn) 58
TABLE 25 Global growth hormones market size, by region, 2014 – 2020 (US$ Mn) 59
TABLE 26 Global purified proteins market size, by region, 2010 – 2013 (US$ Mn) 60
TABLE 27 Global purified proteins market size, by region, 2014 – 2020 (US$ Mn) 61
TABLE 28 Global other market size, by region, 2010 – 2013 (US$ Mn) 62
TABLE 29 Global other market size, by region, 2014 – 2020 (US$ Mn) 63
TABLE 30 Global metabolic disorders market size, by region, 2010 – 2013 (US$ Mn) 65
TABLE 31 Global metabolic disorders market size, by region, 2014 – 2020 (US$ Mn) 66
TABLE 32 Global oncology market size, by region, 2010 – 2013 (US$ Mn) 67
TABLE 33 Global oncology market size, by region, 2014 – 2020 (US$ Mn) 68
TABLE 34 Global neurological disorders market size, by region, 2010 – 2013 (US$ Mn) 69
TABLE 35 Global neurological disorders market size, by region, 2014 – 2020 (US$ Mn) 70
TABLE 36 Global cardiovascular diseases market size, by region, 2010 – 2013 (US$ Mn) 71
TABLE 37 Global cardiovascular diseases market size, by region, 2014 – 2020 (US$ Mn) 72
TABLE 38 Global inflammatory and infectious diseases market size, by region, 2010 – 2013 (US$ Mn) 73
TABLE 39 Global inflammatory and infectious diseases market size, by region, 2014 – 2020 (US$ Mn) 74
TABLE 40 Global others market size, by region, 2010 – 2013 (US$ Mn) 75
TABLE 41 Global others market size, by region, 2014 – 2020 (US$ Mn) 76
TABLE 42 North America scar treatment market size, by country, 2010 – 2013 (US$ Mn) 78
TABLE 43 North America scar treatment market size, by country, 2014 – 2020 (US$ Mn) 79
TABLE 44 U.S. scar treatment market size, by type, 2010 – 2013 (US$ Mn) 81
TABLE 45 U.S. scar treatment market size, by type, 2014 – 2020 (US$ Mn) 82
TABLE 46 U.S. scar treatment market size, by therapeutic application, 2010 – 2013 (US$ Mn) 83
TABLE 47 U.S. scar treatment market size, by therapeutic application, 2014 – 2020 (US$ Mn) 84
TABLE 48 Canada scar treatment market size, by type, 2010 – 2013 (US$ Mn) 86
TABLE 49 Canada scar treatment market size, by type, 2014 – 2020 (US$ Mn) 87
TABLE 50 Canada scar treatment market size, by therapeutic application, 2010 – 2013 (US$ Mn)  88
TABLE 51 Canada scar treatment market size, by therapeutic application, 2014 – 2020 (US$ Mn)  89
TABLE 52 Europe scar treatment market size, by country, 2010 – 2013 (US$ Mn) 92
TABLE 53 Europe scar treatment market size, by country, 2014 – 2020 (US$ Mn) 93
TABLE 54 U.K. scar treatment market size, by type, 2010 – 2013 (US$ Mn) 95
TABLE 55 U.K. scar treatment market size, by type, 2014 – 2020 (US$ Mn) 96
TABLE 56 U.K. scar treatment market size, by therapeutic application, 2010 – 2013 (US$ Mn) 97
TABLE 57 U.K. scar treatment market size, by therapeutic application, 2014 – 2020 (US$ Mn) 98
TABLE 58 Germany scar treatment market size, by type, 2010 – 2013 (US$ Mn) 100
TABLE 59 Germany scar treatment market size, by type, 2014 – 2020 (US$ Mn) 101
TABLE 60 Germany scar treatment market size, by therapeutic application, 2010 – 2013 (US$ Mn) 102
TABLE 61 Germany scar treatment market size, by therapeutic application, 2014 – 2020 (US$ Mn) 103
TABLE 62 France scar treatment market size, by type, 2010 – 2013 (US$ Mn) 105
TABLE 63 France scar treatment market size, by type, 2014 – 2020 (US$ Mn) 106
TABLE 64 France scar treatment market size, by therapeutic application, 2010 – 2013 (US$ Mn)  107
TABLE 65 France scar treatment market size, by therapeutic application, 2014 – 2020 (US$ Mn)  108
TABLE 66 Russia scar treatment market size, by type, 2010 – 2013 (US$ Mn) 110
TABLE 67 Russia scar treatment market size, by type, 2014 – 2020 (US$ Mn) 111
TABLE 68 Russia scar treatment market size, by therapeutic application, 2010 – 2013 (US$ Mn)  112
TABLE 69 Russia scar treatment market size, by therapeutic application, 2014 – 2020 (US$ Mn)  113
TABLE 70 Italy scar treatment market size, by type, 2010 – 2013 (US$ Mn) 115
TABLE 71 Italy scar treatment market size, by type, 2014 – 2020 (US$ Mn) 116
TABLE 72 Italy scar treatment market size, by therapeutic application, 2010 – 2013 (US$ Mn) 117
TABLE 73 Italy scar treatment market size, by therapeutic application, 2014 – 2020 (US$ Mn) 118
TABLE 74 Spain scar treatment market size, by type, 2010 – 2013 (US$ Mn) 120
TABLE 75 Spain scar treatment market size, by type, 2014 – 2020 (US$ Mn) 121
TABLE 76 Spain scar treatment market size, by therapeutic application, 2010 – 2013 (US$ Mn)  122
TABLE 77 Spain scar treatment market size, by therapeutic application, 2014 – 2020 (US$ Mn)  123
TABLE 78 Asia scar treatment market size, by country, 2010 – 2013 (US$ Mn) 125
TABLE 79 Asian scar treatment market size, by region, 2014 – 2020 (US$ Mn) 125
TABLE 80 Japan scar treatment market size, by type, 2010 – 2013 (US$ Mn) 127
TABLE 81 Japan scar treatment market size, by type, 2014 – 2020 (US$ Mn) 128
TABLE 82 Japan scar treatment market size, by therapeutic application, 2010 – 2013 (US$ Mn)  129
TABLE 83 Japan scar treatment market size, by therapeutic application, 2014 – 2020 (US$ Mn)  130
TABLE 84 China scar treatment market size, by type, 2010 – 2013 (US$ Mn) 132
TABLE 85 China scar treatment market size, by type, 2014 – 2020 (US$ Mn) 133
TABLE 86 China scar treatment market size, by therapeutic application, 2010 – 2013 (US$ Mn)  134
TABLE 87 China scar treatment market size, by therapeutic application, 2014 – 2020 (US$ Mn)  135
TABLE 88 India scar treatment market size, by type, 2010 – 2013 (US$ Mn) 137
TABLE 89 India scar treatment market size, by type, 2014 – 2020 (US$ Mn) 138
TABLE 90 India scar treatment market size, by therapeutic application, 2010 – 2013 (US$ Mn)  139
TABLE 91 India scar treatment market size, by therapeutic application, 2014 – 2020 (US$ Mn)  140
TABLE 92 RoW scar treatment market size, by country, 2010 – 2013 (US$ Mn) 141
TABLE 93 Global scar treatment market size, by region, 2014 – 2020 (US$ Mn) 142
TABLE 94 Brazil scar treatment market size, by type, 2010 – 2013 (US$ Mn) 144
TABLE 95 Brazil scar treatment market size, by type, 2014 – 2020 (US$ Mn) 145
TABLE 96 Brazil scar treatment market size, by therapeutic application, 2010 – 2013 (US$ Mn)  146
TABLE 97 Brazil scar treatment market size, by therapeutic application, 2014 – 2020 (US$ Mn)  147
TABLE 98 Australia scar treatment market size, by type, 2010 – 2013 (US$ Mn) 149
TABLE 99 Australia scar treatment market size, by type, 2014 – 2020 (US$ Mn) 150
TABLE 100 Australia scar treatment market size, by therapeutic application, 2010 – 2013 (US$ Mn)  151
TABLE 101 Australia scar treatment market size, by therapeutic application, 2014 – 2020 (US$ Mn)  152
TABLE 102 Abbott Laboratories product categories  158
TABLE 103 Pfizer, Inc. product categories 160
TABLE 104 Eli Lilly and Company  product categories  162
TABLE 105 Sanofi product categories 164
TABLE 106 AbbVie Inc. product categories  167
TABLE 107 Novartis AG product categories 170
TABLE 108 AstraZeneca plc product categories 172
TABLE 109 Amgen, Inc. product categories 175
TABLE 110 Biogen Idec major therapies 178
TABLE 111 GlaxoSmithKline Plc  major product categories 182
TABLE 112 Bristol-Myers Squibb Company major product categories 185
TABLE 113 Bayer AG product categories 187
TABLE 114 Merck & Co., Inc. major product categories 190
TABLE 115 Roche  major product categories 192
TABLE 116 Johnson & Johnson Services, Inc. product categories 195


List of Figures 

FIG. 1 Scar treatment market: Porter’s five forces analysis 19
FIG. 2 Categorization of scar treatment by type 24
FIG. 3 Categorization of scar treatment by therapeutic application 25
FIG. 4 Population aged 60 years and above in major countries, 2000 – 2050 26
FIG. 5 Comparison of percentage of total biopharmaceutical revenues generation by major pharmaceutical companies, 2000 and 2012 29
FIG. 6 Global scar treatment market share, by region, by value, 2013 37
FIG. 7 Global scar treatment market share, by type, by value, 2013 39
FIG. 8 Global scar treatment market share, by therapeutic application, 2013 41
FIG. 9 Global monoclonal antibodies market share, by region, by value, 2013 44
FIG. 10 Global recombinant proteins market share, by region, by value, 2013 46
FIG. 11 Global granulocyte-colony stimulating factor market share, by region, by value, 2013  48
FIG. 12 Global interferons market share, by region, by value, 2013 50
FIG. 13 Global recombinant human insulin market share, by region, by value, 2013 52
FIG. 14 Global erythropoietin market share, by region, by value, 2013 54
FIG. 15 Global vaccines market share, by region, by value, 2013 56
FIG. 16 Global growth hormones market share, by region, by value, 2013 58
FIG. 17 Global purified proteins market share, by region, by value, 2013 60
FIG. 18 Global other market share, by region, by value, 2013 62
FIG. 19 Global metabolic disorders market share, by region, by value, 2013 65
FIG. 20 Global oncology market share, by region, by value, 2013 67
FIG. 21 Global neurological disorders market share, by region, by value, 2013 69
FIG. 22 Global cardiovascular diseases market share, by region, by value, 2013 71
FIG. 23 Global inflammatory and infectious diseases market share, by region, by value, 2013  73
FIG. 24 Global others market share, by region, by value, 2013 75
FIG. 25 North America scar treatment market share, by country, by value, 2013 78
FIG. 26 U.S. scar treatment market share, by type, by value, 2013 80
FIG. 27 U.S. scar treatment market share, by therapeutic application, by value, 2013  83
FIG. 28 Canada scar treatment market share, by type, by value, 2013 85
FIG. 29 Canada scar treatment market share, by therapeutic application, by value, 2013  88
FIG. 30 Europe Scar treatment market share, by country, by value, 2013 91
FIG. 31 U.K. scar treatment market share, by type, by value, 2013 94
FIG. 32 U.K. scar treatment market share, by therapeutic application, by value, 2013  97
FIG. 33 Germany scar treatment market share, by type, by value, 2013 99
FIG. 34 Germany scar treatment market share, by therapeutic application, by value, 2013 102
FIG. 35 France scar treatment market share, by type, by value, 2013 104
FIG. 36 France scar treatment market share, by therapeutic application, by value, 2013 107
FIG. 37 Russia scar treatment market share, by type, by value, 2013 109
FIG. 38 Russia scar treatment market share, by therapeutic application, by value, 2013 112
FIG. 39 Italy scar treatment market share, by type, by value, 2013 114
FIG. 40 Italy scar treatment market share, by therapeutic application, by value, 2013 117
FIG. 41 Spain scar treatment market share, by type, by value, 2013 119
FIG. 42 Spain scar treatment market share, by therapeutic application, by value, 2013 122
FIG. 43 Asia scar treatment market share, by country, by value, 2013 124
FIG. 44 Japan scar treatment market share, by type, by value, 2013 126
FIG. 45 Japan scar treatment market share, by therapeutic application, by value, 2013 129
FIG. 46 China scar treatment market share, by type, by value, 2013 131
FIG. 47 China scar treatment market share, by therapeutic application, by value, 2013 134
FIG. 48 India scar treatment market share, by type, by value, 2013 136
FIG. 49 India scar treatment market share, by therapeutic application, by value, 2013 139
FIG. 50 RoW scar treatment market share, by country, by value, 2013 141
FIG. 51 Brazil scar treatment market share, by type, by value, 2013 143
FIG. 52 Brazil scar treatment market share, by therapeutic application, by value, 2013 146
FIG. 53 Australia scar treatment market share, by type, by value, 2013 148
FIG. 54 Australia scar treatment market share, by therapeutic application, by value, 2013 151
FIG. 55 Competitive landscape of scar treatment market, 2014 153
FIG. 56 Global scar treatment market, by company 2014 (% share) 155
FIG. 57 Abbott Laboratories net sales and net earnings, 2012 – 2014 (US$ Mn) 158
FIG. 58 Pfizer, Inc. total revenue and net income, 2012 – 2014 (US$ Mn) 161
FIG. 59 Eli Lilly and Company revenue and net income, 2012 – 2014 (US$ Mn) 163
FIG. 60 Sanofi net sales and net income, 2012 – 2014 (US$ Mn) 165
FIG. 61 AbbVie, Inc. net sales and net earnings, 2012 – 2014 (US$ Mn) 168
FIG. 62 Novartis AG net sales and net income, 2012 – 2014 (US$ Mn) 170
FIG. 63 AstraZeneca plc revenue and profit, 2012 – 2014 (US$ Mn) 173
FIG. 64 Amgen, Inc. revenue and net income 2012 – 2014 (US$ Mn) 176
FIG. 65 Biogen Idec revenue and net income 2012 – 2014 (US$ Mn) 179
FIG. 66 GlaxoSmithKline plc turnover and profit, 2012 – 2014 (US$ Mn) 183
FIG. 67 Bristol-Myers Squibb Company total revenue and net earnings, 2012 – 2014 (US$ Mn)  186
FIG. 68 Bayer AG net sales and net income, 2011 – 2013 (US$ Mn) 188
FIG. 69 Merck & Co., Inc. sales and net income, 2012 – 2014 (US$ Mn) 191
FIG. 70 Roche sales and net income, 2012 – 2014 (US$ Mn) 193
FIG. 71 Johnson & Johnson Services, Inc., net sales and net earnings, 2012 – 2014 (US$ Mn)  196

Back To Top